Zmpste24−/− mice |
Bone fragility, reduced weight and growth, defective prelamin A processing, early death, muscular weakness, age-dependent cardiac electrical defects |
No severe vascular alterations |
[19,20,21] |
Heterozygous LMNAp.G608G/+ mice |
Ubiquitous progerin accumulation, vascular abnormalities |
Lack rest of features of progeria phenotype |
[22] |
LmnaG609G/G609G mice |
Ubiquitous progerin accumulation, shortened lifespan, reduced weight, main metabolic, bone, and cardiovascular alterations |
Mice do not develop atherosclerosis |
[23] |
Apoe−/− LmnaG609G/G609G mice |
Same phenotype as LmnaG609G/G609G but including the development of atherosclerosis |
- |
[25] |
Apoe−/−LmnaLCS/LCS SM22αCre mice |
Progerin expression restricted to VSMCs. Mice recapitulate vascular features of progeria |
Lack of overt growth defects and other disease symptoms compared to the phenotype observed in LmnaG609G/G609G mice |
[25] |
Apoe−/−LmnaLCS/LCS LysMCre mice |
Progerin expression restricted to macrophages |
Lack of overt growth defects and other disease symptoms compared to the phenotype observed in LmnaG609G/G609G mice and in Apoe−/−LmnaLCS/LCS SM22αCre
|
[25] |
Prog-Tg mice |
Progerin expression restricted to endothelium. Reduced growth, weight, and lifespan. Mice recapitulate many cardiovascular alterations such as profibrotic response and cardiac functional impairment |
Lack of VSMC loss |
[26] |
Knockin heterozygous LMNA c.1824C > T Yucatan minipig |
Expression of progerin and normal lamin A/C, growth retardation, lipodystrophy, skin and bone alterations, cardiovascular alterations, cardiovascular disease, and mortality around puberty |
Difficulty to establish an HGPS minipig colony through conventional breeding |
[27] |